November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant

November 24, 2025

‘It Should Have Never Been Published’ Debate Continues

Experts counter Robert F. Kennedy Jr.’s claims about aluminum adjuvant safety, noting extensive evidence that aluminum-containing vaccines remain effective and well-validated.

KFF Health News

November 24, 2025

Why Youth E-Bike Injuries Are Increasing

Rising youth e-bike use and injuries amid limited federal oversight and evolving state safety rules.

KFF Health News

November 21, 2025

Which Antidepressants Shift Physiology?

Researchers found differences in how antidepressants affect weight, blood pressure, heart rate, and other physiological parameters.

Conexiant

November 20, 2025

Should Antibiotics Be Added After Episiotomy?

Researchers examined whether short-course prophylactic antibiotics reduce postpartum wound complications after episiotomy or second-degree tears.

Conexiant

November 19, 2025

What the Storms Left Behind Was Worse

Severe storm-related mold infestations are contributing to ongoing respiratory and systemic health risks amid significant delays in remediation and disaster recovery support.

KFF Health News

November 18, 2025

‘Designed to Scare People’? New Contraception Data

Hormonal contraception shows overall safety with a modest, short-term rise in breast cancer risk.

KFF Health News

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 18, 2025

Why Do Some Struggle to Hear in Noise?

Researchers examine how lower intellectual ability is linked to poorer multitalker speech perception in neurodivergent individuals with normal hearing. 

Conexiant